A new sustained-release tablet formulation of procainamide.
D000284:Administration, Oral; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002021:Buffers; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D011342:Procainamide / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D012995:Solubility; D013050:Spectrometry, Fluorescence; D013608:Tablets, Enteric-Coated; D013997:Time Factors
D002021:Buffers; D003692:Delayed-Action Preparations; D013608:Tablets, Enteric-Coated; D011342:Procainamide